Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism

Bibliographic Details
Title: Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism
Authors: Byoung Seok Ye, Seong Ho Jeong, Sung Woo Kang, Young H. Sohn, Alzheimer’s Disease Neuroimaging Initiative, Min Cheol Park, Phil Hyu Lee, Kyoungwon Baik, Jin Ho Jung, Younggun Lee
Contributors: Young-Gun Lee, Mincheol Park, Seong Ho Jeong, Sung Woo Kang, Kyoungwon Baik, Jin Ho Jung, Phil Hyu Lee, Young Ho Sohn, Byoung Seok Ye, Sohn, Young Ho
Source: Neurobiology of Aging. 106:223-231
Publisher Information: Elsevier BV, 2021.
Publication Year: 2021
Subject Terms: Male, 0301 basic medicine, Heterozygote, Genotype, Brain / diagnostic imaging, Apolipoprotein E4, Alzheimer Disease / prevention & control, Antioxidants, Cognitive Dysfunction / prevention & control, Brain metabolism, 03 medical and health sciences, Serum uric acid, Cognition, 0302 clinical medicine, Alzheimer Disease, 80 and over, Cognitive Dysfunction / psychology, Humans, Cognitive Dysfunction, Uric Acid / blood, Aged, Aged, 80 and over, Sex Characteristics, Alzheimer Disease / metabolism, Brain, Brain / metabolism, Alzheimer's disease, Uric Acid, 3. Good health, Alzheimer Disease / genetics, Cognitive Dysfunction / metabolism, Positron-Emission Tomography, Cognitive Dysfunction / genetics, Disease Progression, Alzheimer Disease / psychology, Apolipoprotein E4 / genetics, Female
Description: Serum uric acid, a natural antioxidant, may have a protective effect on the progression of Alzheimer's disease (AD). To investigate the effect of serum uric acid on longitudinal cognitive and brain metabolic changes, we utilized data on baseline serum uric acid levels, APOE genotyping, and longitudinal cognitive scores from the Alzheimer's Disease Neuroimaging Initiative for 1,343 participants with normal cognition (NC), mild cognitive impairment (MCI), or dementia. In 979 participants, brain metabolism was measured using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) images. Higher serum uric acid levels exhibited a detrimental effect on NC, whereas a protective trend was observed in individuals with cognitive impairment. Interestingly, higher uric acid levels were associated with a slower decline in cognitive scores and brain metabolism in females with MCI, and this effect was found in APOE4 carriers, but not in non-carriers. Longitudinal AD-like patterns of brain metabolism on FDG-PET images also appeared to mediate the effects of baseline uric acid levels on longitudinal cognitive decline. In summary, higher serum uric acid may interact with APOE4 to alleviate longitudinal metabolic changes and cognitive decline in female MCI patients.
Document Type: Article
Language: English
ISSN: 0197-4580
DOI: 10.1016/j.neurobiolaging.2021.05.003
Access URL: https://pubmed.ncbi.nlm.nih.gov/34311431
https://pubmed.ncbi.nlm.nih.gov/34311431/
https://www.sciencedirect.com/science/article/pii/S0197458021001573
Rights: Elsevier TDM
CC BY NC ND
Accession Number: edsair.doi.dedup.....d2f0c8965021d6cb6f193cfed2565f11
Database: OpenAIRE
Be the first to leave a comment!
You must be logged in first